Aspen Neuroscience Inc. (ASPE) Stock Ticker
ASPE right now
Market factors today
Unlock the full ASPE picture
About Aspen Neuroscience Inc.
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.
ASPE stock facts
| Ticker symbol | ASPE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $356.4M |
| CEO | Damien McDevitt |
| Employees | 120 |
| Headquarters | San Diego, CA, US |
| IPO date | 2026-10-30 |
| Website | www.aspenneuroscience.com |
What you can see for ASPE on Tickr
Live ASPE price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ASPE report.
Rankings
FAQ
What is the ticker symbol for Aspen Neuroscience Inc.?
The ticker symbol for Aspen Neuroscience Inc. is ASPE, listed on the NASDAQ.
What is ASPE?
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company…